FDA Clears AI Tool to Flag Peripheral Artery Disease Early

FDA approves vascular disease detection software

GuideAI Health has received FDA 510(k) clearance for an AI-powered software system designed to identify early signs of peripheral artery disease in medical imaging studies. The Boston-based company, founded by radiologists, developed VascularAssist Occlusion Triage (VAOT) to automatically flag suspected vascular occlusions in lower extremity scans, prompting prioritized clinical review.

The software analyzes both 2D and 3D imaging exams and has demonstrated high patient-level sensitivity in detecting vascular blockages. When the system identifies potential occlusions, it generates alerts within the radiology workflow, enabling faster clinical decision-making.

Why it matters

Peripheral artery disease frequently goes undiagnosed until patients develop severe complications. Those with chronic limb-threatening ischemia face substantial amputation risk when treatment is delayed. Automated triage tools that surface high-risk cases from routine imaging workflows could reduce the time between detection and intervention—a critical factor in preserving limb function. For health systems managing high imaging volumes, AI-assisted prioritization may help radiologists focus attention where it's most urgently needed.

Addressing a detection gap

Raj Shah, CEO of GuideAI Health and a physician with an MBA, characterized the clearance as a defining milestone for the company. He noted that peripheral vascular disease is commonly missed or identified late, with serious consequences for patients. The software aims to integrate AI-powered triage directly into existing radiology systems, helping clinicians spot vascular disease earlier and route patients to appropriate care more quickly.

Shah described the FDA clearance as the first step in a broader strategy to establish new standards for AI-driven vascular care. The company's focus on workflow integration reflects a practical approach to clinical AI deployment—embedding decision support at the point where imaging data is first reviewed rather than requiring separate analysis steps.

Clinical workflow integration

VascularAssist Occlusion Triage is designed to operate within the radiology reading environment, automatically evaluating images as they're acquired. This approach contrasts with retrospective analysis tools that require manual case selection. By functioning as an always-on screening layer, the software aims to catch cases that might otherwise be deprioritized or overlooked in busy clinical settings.

The system's ability to process both 2D and 3D imaging formats gives it flexibility across different scanning protocols and equipment configurations. This technical versatility may ease adoption in health systems with varied imaging infrastructure.

Details on the software's training data, validation studies, and performance metrics were first reported by Cardiovascular Business. GuideAI Health has not yet disclosed pricing, availability timelines, or initial deployment partners for the newly cleared system.